Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Awaits Word On Commissioner McClellan; Is He Headed To CMS?

This article was originally published in The Tan Sheet

Executive Summary

The public speculation about FDA Commissioner McClellan's next move within the Bush Administration indicates the importance of the Medicare prescription drug bill to the White House heading into the November elections

You may also be interested in...

CDER Deputy Galson Will Run Drug Center For At Least Six Months

Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches

HHS Puts Stamp On FDA: Crawford Named Acting Commissioner

The appointment of former Virginia Tech Center for Food & Nutrition Policy head Lester Crawford, PhD/DVM, as acting commissioner puts FDA in the hands of HHS Secretary Tommy Thompson's preferred choice to lead the agency

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts